AbbVie Trims Full-Year Profit Outlook Due to Apogee Acquisition
Yahoo Finance · Jul 31, 2026 · Apogee Therapeutics, Inc. Common Stock (APGE)
AbbVie (ABBV) lowered its full-year earnings guidance on Friday to account for the expected dilution
Not investment advice. Cached headline, not a full reprint.